Skip to Main Content

Author Details

Carlos E de Andrea
University of Navarra
2010
78
25
PMIDPaper TitleJournal TitlePublished Year
37527007Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).Clin Cancer Res2024
34429353Reference standards for gene fusion molecular assays on cytological samples: an international validation study.J Clin Pathol2023
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
37595047CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.Sci Adv2023
37495174Serum levels of S-100 protein are directly proportional to the size, number, thickness and degree of cellularity of congenital melanocytic nevi.J Am Acad Dermatol2023
37258670In situ tumour arrays reveal early environmental control of cancer immunity.Nature2023
37188783Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nat Med2023
37155406Synplex: In Silico Modeling of the Tumor Microenvironment From Multiplex Images.IEEE Trans Med Imaging2023
37040772Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.Cell Rep Med2023
36478221Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.Cancer Immunol Res2023
36472908Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury.JCI Insight2023
36710050Characterization of the immune infiltrate in mouse tissue by multiplex immunofluorescence.Methods Cell Biol2023
36309960Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP.Ann Neurol2023
36116717In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis.J Hepatol2023
35217454NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.Med Image Anal2022
35771565A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.Cancer Discov2022
35767439Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.N Engl J Med2022
35393952Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.JCI Insight2022
35714708Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19.Chest2022
36581331Biomarkers of tumor-reactive CD4<sup>+</sup> and CD8<sup>+</sup> TILs associate with improved prognosis in endometrial cancer.J Immunother Cancer2022
36467415Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.Front Cell Dev Biol2022
36169332The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.J Pathol2022
36130020Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.Cancer Res2022
36012390High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.Int J Mol Sci2022
35918123Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.J Immunother Cancer2022
33766954TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study.J Clin Pathol2022
35191482Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.Cancer Discov2022
33402737The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1<sup>+</sup> tumour-infiltrating lymphocytes.Br J Cancer2021
33870575Utilisation of cytological samples for multiplex immunofluorescence assay.Cytopathology2021
33672863Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling.Cancers (Basel)2021
33889513Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.Transl Lung Cancer Res2021
33658304SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.J Immunother Cancer2021
34737427Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.Nat Genet2021
34824158Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy.J Immunother Cancer2021
34184758Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8.J Pathol2021
34150764Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.Front Cell Dev Biol2021
34200459Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy.Cancers (Basel)2021
34026795PD-L1 in Cytological Samples: A Review and a Practical Approach.Front Med (Lausanne)2021
33376098Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.Clin Cancer Res2021
33376096IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy.Clin Cancer Res2021
32289253CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.Immunity2020
35121837Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.Nat Cancer2020
31874858Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.Cancer Res2020
33126649Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of <i>KRAS</i>-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8<sup>+</sup> T Cells.Cancers (Basel)2020
32657547A comprehensive diagnosis of a desmoplastic small round cell tumor of unusual location based on fine-needle aspiration cytology: Report of a case arising in the parotid gland and review of the literature.Diagn Cytopathol2020
32934876Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors.Oncoimmunology2020
32591586Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence.Mod Pathol2020
32839288Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.Thorax2020
32292509Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death.Theranostics2020
32291396Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis.Mod Pathol2020
  • 1 - 50 of 78

Recommended Authors

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 0
Institute of Pathology, Charite Universitatsmedizin Berlin
Career Start Year 2013
Number of shared co-authors 1
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 2
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Olivia Newton-John Cancer Research Institute
Career Start Year 2003
Number of shared co-authors 1
St. Anna Children's Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Monash University
Career Start Year 2000
Number of shared co-authors 1
Western University
Career Start Year 1999
Number of shared co-authors 1
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Uppsala University
Career Start Year 1997
Number of shared co-authors 1
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 4
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 1

Collaborators

CIMA-Universidad de Navarra
Co-authored papers 5
Center for Applied Medical Research.
Co-authored papers 5
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
Leiden University Medical Center
Co-authored papers 2
Co-authored papers 2
University of Navarra, Center for Applied Medical Research
Co-authored papers 2
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 2
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
National Center for Biotechnology
Co-authored papers 1
Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
Weill Cornell Medical College, New York Presbyterian Hospital
Co-authored papers 1
Northwestern University
Co-authored papers 1
Co-authored papers 1
University Health Network
Co-authored papers 1
Center for Applied Medical Research (CIMA)
Co-authored papers 1
Clinica Universidad de Navarra
Co-authored papers 1
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 1
University Children's Hospital Zurich
Co-authored papers 1
University College London, UCL Cancer Institute
Co-authored papers 1
Moffit Cancer Center
Co-authored papers 1
Lehigh Valley Topper Cancer Institute
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
DNATrix Inc.
Co-authored papers 1
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers 1
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Co-authored papers 1
University of Arkansas for Medical Sciences
Co-authored papers 1
Rutgers Cancer Institute of New Jersey, Rutgers University
Co-authored papers 1